netFormulary
 Report : A-Z NHS England items in Formulary 11/07/2020 15:18:30
[Back]
 
Section Status NHS England Name
08.02.04 Restricted Use MHS England Beta-interferon-1a Avonex®
08.02.04 Restricted Use MHS England Beta-interferon-1b Extavia®
08.02.04 Restricted Use MHS England Beta-interferon-1b Betaferon®
08.02.04 Restricted Use MHS England Canakinumab Ilaris®
08.02.04 Restricted Use MHS England Cladribine Mavenclad®
05.03.01 Restricted Use MHS England Cobicistat  
05.03.03 Restricted Use MHS England Daclatasvir  
05.03.01 Formulary MHS England Darunavir, Cobicistat, Emtricitabine and tenofovir alafenamide Symtuza®
05.03.03 Restricted Use MHS England Dasabuvir  
05.03.01 Restricted Use MHS England Dolutegravir 
05.03.01 Restricted Use MHS England Dolutegravir & lamivudine Dovato®
05.03.01 Restricted Use MHS England Dolutegravir, Rilpivirine Juluca®
05.03.01 Restricted Use MHS England Doravirine Pifeltro®
03.07 Restricted Use MHS England Dornase Alfa Pulmozyme®
05.03.03 Restricted Use MHS England Elbasvir and grazoprevir Zepatier®
04.08.01 Formulary MHS England Everolimus Votubia
08.02.04 Restricted Use MHS England Fingolimod Gilyena®
08.02.04 Restricted Use MHS England Glatiramer Acetate 
08.02.04 Restricted Use MHS England Interferon beta 
08.02.04 Formulary MHS England Interferon beta-1a Rebif®
03.07 Restricted Use MHS England Ivacaftor  
05.03.03 Restricted Use MHS England Ledipasvir and sofosbuvir  Harvoni®
02.12 Formulary MHS England Lomitapide Lojuxta
03.07 Restricted Use MHS England Lumacaftor/ Ivacaftor  Orkambi®
03.07 Restricted Use MHS England Mannitol  
08.02.04 Restricted Use MHS England Natalizumab  Tysabri®
14.05 Restricted Use MHS England Normal Immunoglobulin  Octagam 10%®
14.05 Restricted Use MHS England Normal Immunoglobulin  Privigen®
14.05 Restricted Use MHS England Normal Immunoglobulin  Gamunex®
14.05 Restricted Use MHS England Normal Immunoglobulin IQYMUNE®
08.02.04 Restricted Use MHS England Ocrelizumab Ocrevus®
05.03.03 Restricted Use MHS England Ombitasvir, paritaprevir, and ritonavir  Viekirax®
05.03.05 Restricted Use MHS England Palivizumab Synagis®
03.11 Restricted Use MHS England Pirfenidone  
05.03.03 Restricted Use MHS England Simeprevir 
05.03.03 Restricted Use MHS England Sofosbuvir 
05.03.03 Restricted Use MHS England Sofosbuvir, velpatasvir, voxilaprevir Vosevi®
05.03.03 Restricted Use MHS England Sofosbuvir/valpatasvir Epclusa®
05.03.03 Restricted Use MHS England Telaprevir 
03.07 Restricted Use MHS England Tezacaftor/ Ivacaftor Symkevi®
Leicestershire Health Community